Zaphiro is a Swiss company leader in Smart Grid applications aimed at power distribution operators, helping them optimise the monitoring and automation of medium voltage power grids through software solutions integrated with proprietary or third-party hardware. Founded by three Italian researchers from EPFL, Zaphiro keeps innovation at the core of its business strategy, developing disruptive solutions in the energy distribution market.

Synthara wants to make in-memory computation universal. Its in-memory computing solutions are easy to integrate into a wide variety of chips (MCUs, DSPs, FPGAs and AI). Synthara actively works with several companies, including Bosch and other market leaders, to create their next-generation products. Synthara has won a number of awards and grants totalling several million euros from various companies such as Intel Ignite, the European Space Agency, Innosuisse and others.

Renaissance Fusion is one of the few European start-ups in the nuclear fusion sector with a revolutionary solution to the problem of complexity, cost and development time to exploit this limitless source of energy. Their unique solution is based on the proven 'stellarator' reactor architecture and combines it with a modular design and a newly conceived high temperature superconducting magnets concept. The technologies and intellectual property developed by Renaissance Fusion also have exciting potential uses including medical imaging and energy storage applications.

TOffeeAM stands for Topology Optimisation For Fluids EnginEEring and Additive Manufacturing.

TOffee is an Imperial College spin-off that has created and continuously updates cloud-based multi-physics software that automates the design process in order to achieve maximum performance of thermofluidic components based on multi-objective optimisation.  At the heart of TOffee is a multi-physics solver that solves thermal and fluid-dynamic equations within the specified design space, which is why the application is already being used by several large industrial groups from the aeronautics to the oil and gas and automotive sectors. 

DeepMirror was founded in 2019 by scientists at the University of Cambridge, who realised how cutting-edge structural Machine Learning techniques could enable biopharmaceutical R&D teams to run fewer unnecessary experiments and find better drugs more quickly. A team made up of leading specialists at the frontier of biotechnology, physics and artificial intelligence is working to create a platform that will be a great support in the search for new drugs and new genetic therapies.

Founded in 2020 by two of the world's leading experts in the field of quantum networks, NodeQ (NodeQuantum) is working on the development of a complex application to configure, optimise and monitor in real time the new communication networks within both public and private sensitive organisations that face the risks brought about by the emergence of quantum de-cryptography technologies.

Hylomorph is an innovative medtech company that designs biomaterials that form a barrier between implants and surrounding biological tissues to prevent post-operative complications and improve the quality of life of patients and the work of healthcare professionals. 

The proprietary CellSense technology was developed in the state-of-the-art laboratories of the Swiss Federal Institute of Technology Zurich (ETH)

QuantActions has developed a new way of assessing the status of cognitive function of the brain in a simple, inexpensive, scientifically proven and repeatable way, based solely on the way the user interacts with their smartphone screen. Developed from research by the University of Zurich and the ETH, QuantActions' technology promises to revolutionise the way in which we can diagnose and monitor various diseases (degenerative and otherwise) that affect our brains.

Nagi Bioscience is a startup at the forefront of innovative technologies, developing newly developed laboratory equipment to offer alternative solutions to animal clinical trials.

A spin-off of EPFL and located in the heart of Switzerland's "Health Valley," Nagi works to revolutionize drug development pipelines by introducing new toxicology testing standards that enable faster, more scalable, efficient and ethical methods.

Greenjets Ltd is a startup co-founded in 2021 by Anmol Maohar and Guido Montersino, two researchers with a strong background in propulsion engineering, and based in Bedforshire.

Zero-emission aviation, such as drones, aerotaxis and electric planes, represent the third revolution in aerospace. Greenjets is developing electric-powered engines that will contribute to the growth of this market, taking into consideration not only performance and fuel consumption aspects, but also noise aspects.

ANNAIDA is experimenting with a new non-invasive technology based on micro magnetic resonance technology (MMRT) to investigate the chemistry within microscopic life while maintaining its full integrity. Annaida promises to improve the analysis of cellular processes and provide a better understanding of its metabolic footprint. The unprecedented scale of the developed device allows for precise understanding of cells ranging from embryos to stem cell organoids and much more.

Fluorokis an Oxford University spin-out that is reinventing the way fluorochemical compounds are produced. Fluorine-based compounds are fundamental to our daily lives (agrochemicals, drugs, anaesthetics, polymers and materials) and Fluorok is developing a disruptive, safe, efficient and sustainable fluorination technology for a cleaner planet and a brighter future. Founded by Prof. V Gouverneur and Dr. G. Pupo, Fluorok's mission is to find new solutions to improve people's health and food availability while reducing our impact on the planet.

VitreaLab is a research and development company focusing on innovative photonic solutions for the lightning and display sector. Located in Vienna, Austria, it is a a spin-off company from the Quantum Group at the University of Vienna. By using glass-based waveguides VitreaLab envisions revolutionary energy-efficient, high luminosity pico-projectors with a broad spectrum of applications such as AR (Augmented Reality) smart glasses  and holographic displays. 

MintNeuro, a spin-off from Imperial College London, is at the forefront of developing next-generation neural implants using advanced semiconductor technology. Their mission is to improve patient outcomes for neurological conditions by offering high-performance solutions with minimally invasive procedures. The team combines leading expertise in neuroscience, microtechnology, and implantable neural interfaces, alongside extensive medtech industry experience and clinical knowledge.